Triptorelin, leuprorelin acetate clinical trials

PATHWAYS TRIAL, PATHWAYS HORIZON INTENSIVE, PATHWAYS CONNECT

The PATHWAYS study looks at puberty-stopping medicines for young people with gender incongruence (their gender identity doesn't match their birth sex). It aims to understand how these medicines affect their health and well-being, comparing starting treatment now versus waiting a year.